Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prostate Cancer Diagnostics Using a Combination of the Stockholm3 Blood Test and Multiparametric Magnetic Resonance Imaging.

European urology - 1 Dec 2018

Grönberg Henrik, Eklund Martin, Picker Wolfgang, Aly Markus, Jäderling Fredrik, Adolfsson Jan, Landquist Martin, Haug Erik Skaaheim, Ström Peter, Carlsson Stefan, Nordström Tobias

Abstract excerpt

BACKGROUND: More specific diagnostic for prostate cancer is needed to decrease overdetection and number of diagnostic procedures. OBJECTIVE: To assess the performance of combining a blood-based biomarker panel and magnetic resonance imaging (MRI)-targeted biopsies for prostate cancer detection. DESIGN, SETTING, AND PARTICIPANTS: We used a prospective, multicenter, paired diagnostic study design. A total of 532...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clinical Decision-Making
Share to Denmark

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Kallikreins

Share to Neoplasm Grading

Share to Predictive Value of Tests

Share to Prostate-Specific Antigen

Share to Prostatic Neoplasms

Share to Sweden

Source

Identifiers

PMID: 30001824
DOI: 10.1016/j.eururo.2018.06.022

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prostate Cancer Diagnostics Using a Combination of the Stockholm3 Blood Test and Multiparametric Magnetic Resonance Imaging.PMID 30001824Read ↗

The Stockholm3 blood-test predicts clinically-significant cancer on biopsy: independent validation in a multi-center community cohort.Semantic proximity Read ↗

Prostate cancer screening in men aged 50-69 years (STHLM3): a prospective population-based diagnostic study.Semantic proximity Read ↗

The Stockholm-3 Model for Prostate Cancer Detection: Algorithm Update, Biomarker Contribution, and Reflex Test Potential.Semantic proximity Read ↗

Optimizing Detection of Clinically Significant Prostate Cancer through Nomograms incorporating MRI, Clinical Features, and Advanced Serum BiomarkersSemantic proximity Read ↗

Impact of a new diagnostic pathway for prostate cancer - From systematic transrectal to targeted MRI fusion transperineal biopsiesSemantic proximity Read ↗

Biomarkers in Localized Prostate Cancer: Towards a Personalized MedicineSemantic proximity Read ↗

Beyond blood biomarkers: the role of SelectMDX in clinically significant prostate cancer identificationSemantic proximity Read ↗

Assessment of a Polygenic Risk Score in Screening for Prostate CancerSemantic proximity Read ↗

Magnetic Resonance Imaging-based Prostate Cancer Screening in Carriers of Pathogenic Germline Mutations: Interim Results from the Initial Screening Round of the Prostate Cancer Genetic Risk Evaluation and Screening Study.Semantic proximity Read ↗

Prostate cancer diagnosis in the new millennium: strengths and weaknesses of prostate-specific antigen and the discovery and clinical evaluation of prostate cancer gene 3 (PCA3).Semantic proximity Read ↗

Combined radiomics and liquid biopsy reflect tumor biology towards multimodal non-invasive prostate cancer risk stratificationSemantic proximity Read ↗

Redefining Prostate Cancer Precision: Radiogenomics, Theragnostics, and AI- Driven BiomarkersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.